Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
07/2006
07/20/2006WO2006076640A1 Monoclonal antibodies that bind or neutralize hepatitis b virus
07/20/2006WO2006076636A1 Amine polymer-modified nanoparticulate carriers
07/20/2006WO2006076619A1 Water-soluble tetrazolium salts
07/20/2006WO2006076584A2 Kid31 and antibodies that bind thereto
07/20/2006WO2006076371A2 Method of quantitative immunohistochemistry and in situ hybridization
07/20/2006WO2006076225A2 Methods and systems for identifying and monitoring s-nitrosothiols in biological samples
07/20/2006WO2006076100A2 Tubulin isotype screening in cancer therapy using halichondrin b analogs
07/20/2006WO2006076034A2 Stabilized two component system for chemilumiescent assay in immunodiagnostics
07/20/2006WO2006076027A2 Biofabrication of transistors including field effect transistors
07/20/2006WO2006076025A2 Immune cell biosensors and methods of using same
07/20/2006WO2006075974A1 Water-soluble nanocrystals and methods of preparing them
07/20/2006WO2006075966A1 A versatile flow path
07/20/2006WO2006075965A1 A method for detecting an at least bivalent analyte using two affinity reactants
07/20/2006WO2006075964A1 A method for co-transporting a reactant with an amphiphilic macromolecular substans in a microfluid transport conduit
07/20/2006WO2006075784A1 ANTI-α9 INTEGRIN ANTIBODY AND THE USE THEREOF
07/20/2006WO2006075735A1 Array and hybridization method
07/20/2006WO2006075682A1 Gene markers and utilzation of the same
07/20/2006WO2006075626A1 Method of examining inflammatory disease and method of screening remedy for inflammatory disease
07/20/2006WO2006075612A1 Method of assaying protozoan oocyst and detection reagent therefor
07/20/2006WO2006075497A1 Probe unit, apparatus for identifying nucleotide region and method of identifying nucleotide region
07/20/2006WO2006075185A1 Process for preparation of coated polymer particles containing superparamagnetic crystals
07/20/2006WO2006075172A2 Methods for identifying compounds capable of modulating cftr/ck2 interaction and/or cftr phosphorylation by ck2
07/20/2006WO2006075164A1 Sensing in meat products and the like
07/20/2006WO2006075142A2 FORMS OF FACTOR XIIa
07/20/2006WO2006075049A1 Device for determining metallic contaminant particles in lubricating grease
07/20/2006WO2006075030A2 Biosensor for determining the biochemical oxygen demand (bod) by respirometry
07/20/2006WO2006074927A1 Novel electrode design for biosensor
07/20/2006WO2006074914A2 Human rna helicase and therapeutic uses thereof
07/20/2006WO2006074906A1 Method and device for quantifying proteins
07/20/2006WO2006074802A1 Use of a trpc channel for the treatment of a cardiovascular disease
07/20/2006WO2006074547A1 Nitrogen-regulated sugar sensing gene and protein and modulation thereof
07/20/2006WO2006074506A1 Non-destructive testing of the lining of a process vessel
07/20/2006WO2006061626A3 Complexes and methods
07/20/2006WO2006060591A3 Determination of cell viability and phenotype
07/20/2006WO2006060419A9 Biomarkers for pre-selection of patients for anti-igf1r therapy
07/20/2006WO2006055676A3 Molecular basis for the identification of chemotherapy resistance in human tumors and the treatment thereof
07/20/2006WO2006048270A3 Methods of detecting leukemia and its subtypes
07/20/2006WO2006046108A3 Diagnosis of male infertility by measuring tissue factor pathway inhibitor
07/20/2006WO2006045750A3 T-cell stimulatory peptides from the melanoma-associated chondroitin sulfate proteoglycan and their use
07/20/2006WO2006045476A3 Gpr17 modulators, method of screening and uses thereof
07/20/2006WO2006039173A3 Uses of an endothelial cell receptor
07/20/2006WO2006034195A3 Quantitative and qualitative chelation measuring methods and materials
07/20/2006WO2006029836A3 Breast cancer proteins
07/20/2006WO2006028871A9 Blood urea nitrogen (bun) sensor
07/20/2006WO2006026404A3 Assay for detecting tuberculosis in nonhuman primates
07/20/2006WO2006019431A3 Methods and kits for measuring adamts13/fxi complexes
07/20/2006WO2006005470A3 Diagnostics and therapeutics for diseases associated with mas related g-protein coupled receptor e (mrge)
07/20/2006WO2006001965A3 Reducing the risk of human anti-human antibodies through v gene manipulation
07/20/2006WO2005120553A3 Insulin-independent, bone morphogenetic protein (bmp)-mediated uptake of blood glucose by peripheral cells and tissues
07/20/2006WO2005119234A3 Measuring device and methods for use therewith
07/20/2006WO2005114215A9 Method of improving t cell receptors
07/20/2006WO2005108949A3 Methods, compositions and compound assays for inhibiting amyloid-beta protein production
07/20/2006WO2005103300A3 Pattern recognition method for diagnosis of systemic autoimmune diseases
07/20/2006WO2005097190A3 Systems and methods for providing a stem cell bank
07/20/2006WO2005093103A3 Development and use of fluorescent probes of unbound analytes
07/20/2006WO2005089045A3 Prognostic methods for congestive heart failure
07/20/2006WO2005075508A3 Hyperactive stat molecules and their use in assays employing gene activation
07/20/2006WO2005050214A3 Methods and means relating to hepatitis b infection
07/20/2006WO2005047509A3 The mycolactone locus : an assembly line for producing novel polyketides, with therapeutic and prophylatic uses
07/20/2006WO2005033833A3 Computer software and algorithms for systems biologically linked to cellular phenotype
07/20/2006WO2005003164A9 Compositions and methods for diagnosing and treating asthma or other allergic or inflammatory diseases
07/20/2006WO2004059280A3 Methods, compositions and kits for biomarker extraction
07/20/2006WO2004028352A3 Methods for prediction and prognosis of cancer, and monitoring cancer therapy
07/20/2006WO2004007672A3 Methods and materials relating to novel polypeptides and polynucleotides
07/20/2006WO2003066808A3 Mammalian migration inducting gene and methods for detection and inhibition of migrating tumor cells
07/20/2006US20060162002 Drug screening; assaying for activators of the heat shock factor 1 (HSF-1) protein, which increases lifespan when overexpressed in an organism; antiaging agents
07/20/2006US20060161408 Population pharmacokinetic modeling and analysis (PDX-POP™)
07/20/2006US20060161366 Multiphase coriolis flowmeter
07/20/2006US20060160990 Fluorescent protein and chromoprotein
07/20/2006US20060160835 Methods and compositions for treatment of central nervous system disorders
07/20/2006US20060160764 LIMKs as modifiers of p53 pathway and methods of use
07/20/2006US20060160762 Methods for the treatment, diagnosis, and prognosis of cancer
07/20/2006US20060160730 Administering pro-adrenomedullin N-terminal 20 peptide to induce neovascularization; use in treating coronary artery disease, peripheral vascular disease, and wounds; skin and organ (including heart) grafts
07/20/2006US20060160728 Diagnostic and therapeutic use of ensandin-0138 gene and protein for neurodegenerative diseases
07/20/2006US20060160723 Glycoproteins having lipid mobilising properties and therapeutic applications thereof
07/20/2006US20060160246 Graphitic nanotubes in luminescence assays
07/20/2006US20060160245 Binding analyte to patterned receptor layer on substrate; analyzer may include a light source, a photodiode, a microprocessor and a display system; performing an algorithm that contains as variables the intensity of the diffracted and non-diffracted light
07/20/2006US20060160240 Indicator for assessing body odor, process for producing the same, body odor assessment method, method of assessing efficaciousness of deodorant and kit for conveniently assessing body odor
07/20/2006US20060160238 Method and device for analysis, verification and quality assurance of drugs for injection or infusion
07/20/2006US20060160236 Diagnosis of conditions associated with decreased arginine bioavailability
07/20/2006US20060160235 Separation of denatured proteins in free solution
07/20/2006US20060160234 Methods for assessing polypeptide array quality
07/20/2006US20060160233 Ig heavy chain, ig kappa, ig lambda biopolymer markers predictive of alzheimers disease
07/20/2006US20060160232 Complement c3 precursor biopolymer markers predictive of type ii diabetes
07/20/2006US20060160231 Linear analysis of polymers
07/20/2006US20060160230 Wipes and methods for removal of metal contamination from surfaces
07/20/2006US20060160229 Method of measurement of nucleated red blood cells
07/20/2006US20060160228 Measuring biodegradation rate of a non-natural organic compound safely, simply, rapidly, and accurately without providing any special measures against radiation; without enriching a measurement sample with an expensive radioactive carbon isotope 14C
07/20/2006US20060160227 Method of monitoring treating agent residuals and controlling treating agent dosage in water treatment processes
07/20/2006US20060160225 making synthetic soil for use in testing cleaning products for dirt removal; provides a consistent test for these cloths and cleaning devices to allow comparisons that will accurately correlate to how these cloths and devices will perform
07/20/2006US20060160224 Fish labeling system
07/20/2006US20060160208 Multi-well plate with alignment grooves for encoded microparticles
07/20/2006US20060160207 Cucurbituril derivative-bonded solid substrate and biochip using the same
07/20/2006US20060160187 Combinatorial interleukin-2 muteins
07/20/2006US20060160170 Method and device of rapid antigen extraction
07/20/2006US20060160166 Rapid triglyceride assay for use in pulp pitch control
07/20/2006US20060160164 Immunoassay device with immuno-reference electrode
07/20/2006US20060160163 Method of saying alastin digestion product and assay kit, method of detecting aortic dissection and detection kit
07/20/2006US20060160162 Capillary array and related methods
07/20/2006US20060160161 Methods for assessing antibodies to neurodegenerative disease-associated antigens